Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Research
Nobel winner turns rogue T cells into their own treatment
By tweaking signaling pathways in the lab, disease-causing T cells were converted into targeted regulatory T cells that suppress inflammation.
Darren Incorvaia
Oct 23, 2025 10:35am
British biotech elevates with $70M and midstage arthritis asset
Oct 21, 2025 7:01pm
How Nobel-winning cells could become a 'universal drug'
Oct 21, 2025 2:00pm
Dianthus offers up to $1B for China biotech’s autoimmune asset
Oct 16, 2025 10:57am
Diabetes drug soothes brain inflammation in female mice with MS
Oct 15, 2025 6:16pm
Cabaletta's CAR-T wipes out B cells with no preconditioning
Oct 10, 2025 11:11am